Absence of cognitive impairment or decline in preclinical Alzheimer's disease

Neurology

Volumn 56, Issue 3, 2001, Pages 361-367

  Goldman, W P ^a   Price, J L ^b   Storandt, M ^a   Grant, E A ^a   McKeel Jr , D W ^b   Rubin, E H ^a   Morris, John C ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; RETROSPECTIVE STUDY; SENILE PLAQUE; TEMPORAL LOBE;

EID: 0035852871     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.3.361     Document Type: Article

References (48)

1. Alzheimer changes in nondemented patients younger than sixty-five: Possible early stages of Alzheimer's disease and senile dementia of Alzheimer type
2. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging
3. Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals
4. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease
5. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease
6. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
7. Alzheimer neuropathologic alterations in aged cognitively normal subjects
8. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons
9. Neuropsychological detection and characterization of preclinical Alzheimer's disease
10. The "preclinical phase" of probable Alzheimer's disease: A 13-year prospective study of the Framingham cohort
11. The course of cognitive impairment in preclinical Alzheimer disease: Three- and 6-year follow-up of a population-based sample
12. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framington cohort
13. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
14. The effects of preclinical dementia on estimates of normal cognitive functioning in aging
15. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old
16. A prospective study of cognitive function and onset of dementia in cognitively healthy elders
17. Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging
18. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease
19. "Preclinical" AD revisited: Neuropathology of cognitively normal older adults
20. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
21. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
22. Validation of clinical diagnostic criteria for Alzheimer's disease
23. The Clinical Dementia Rating (CDR): Current version and scoring rules
24. Reliability of the Washington University Clinical Dementia Rating
25. Clinical Dementia Rating training and reliability in multicenter studies: The Alzheimer's Disease Cooperative Study experience
26. Retrospective postmortem dementia assessment: Validation of a new clinical interview to assist neuropathologic study
27. Progression of senile dementia of the Alzheimer type on a battery of psychometric tests
28. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
29. Very mild senile dementia of the Alzheimer type. II. Psychometric test performance
30. Cognitive function and prediction of dementia in old age
31. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study
32. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change: Report of a National Institute of Mental Health Work Group
33. Mild cognitive impairment: Clinical characterization and outcome
34. Evidence that age-associated memory impairment is not a normal variant of aging
35. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
36. Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild Alzheimer's disease
37. New neuropathological criteria for Alzheimer disease
38. Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe
39. 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease
40. An analysis of certain psychological tests used in the evaluation of brain injury
41. Speed functions, vocabulary ability, and age